The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Chemical chaperone therapy for brain pathology in G M1 -gangliosidosis
Open accessAbstract
We synthesized a galactose derivative, N- octyl-4-epi-β-valienamine (NOEV), for a molecular therapy (chemical chaperone therapy) of a human neurogenetic disease, β-galactosidosis (G M1 -gangliosidosis and Morquio B disease). It is a potent inhibitor of lysosomal β-galactosidase in vitro . Addition of NOEV in the culture medium restored mutant enzyme activity in cultured human or murine fibroblasts at low intracellular concentrations, resulting in a marked decrease of intracellular substrate storage. Short-term oral administration of NOEV to a model mouse of juvenile G M1 -gangliosidosis, expressing a mutant enzyme protein R201C, resulted in significant enhancement of the enzyme activity in the brain and other tissues. Immunohistochemical stain revealed a decrease in the amount of G M1 and G A1 in neuronal cells in the fronto-temporal cerebral cortex and brainstem. However, mass biochemical analysis did not show the substrate reduction observed histochemically in these limited areas in the brain probably because of the brief duration of this investigation. Chemical chaperone therapy may be useful for certain patients with β-galactosidosis and potentially other lysosomal storage diseases with central nervous system involvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebícek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02161-9 · Cited by 744
Fan, J.-Q., Ishii, S., Asano, N., & Suzuki, Y. (1999) · Nature Medicine · doi:10.1038/4801 · Cited by 614
Self-citationQuantitative isolation of total glycosphingolipids from animal cells
Saito, T., & Hakomori, S.-I. (1971) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39537-7 · Cited by 550
The Use of Sep‐Pak™ C18 Cartridges During the Isolation of Gangliosides
Williams, M. A., & McCluer, R. H. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb12515.x · Cited by 475
Gangliosides of human, bovine, and rabbit plasma
Yu, R. K., & Ledeen, R. W. (1972) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39374-3 · Cited by 352
Prevention of Lysosomal Storage in Tay-Sachs Mice Treated with N -Butyldeoxynojirimycin
Platt, F. M., Neises, G. R., Reinkensmeier, G., Townsend, M. J., Perry, V. H., Proia, R. L., Winchester, B., Dwek, R. A., & Butters, T. D. (1997) · Science · doi:10.1126/science.276.5311.428 · Cited by 340
Jeyakumar, M., Butters, T. D., Cortina-Borja, M., Hunnam, V., Proia, R. L., Perry, V. H., Dwek, R. A., & Platt, F. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6388 · Cited by 267
Sugimoto, Y., Ninomiya, H., Ohsaki, Y., Higaki, K., Davies, J. P., Ioannou, Y. A., & Ohno, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221181998 · Cited by 105
Self-citationβ-Galactosidase-deficient mouse as an animal model for GM1-gangliosidosis
Matsuda, J., Suzuki, O., Oshima, A., Ogura, A., Noguchi, Y., Yamamoto, Y., Asano, T., Takimoto, K., Sukegawa, K., Suzuki, Y., et al. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018573518127 · Cited by 103
Self-citation
Cited by
Schnaar, R. L., Gerardy-Schahn, R., & Hildebrandt, H. (2014) · Physiological Reviews · doi:10.1152/physrev.00033.2013 · Cited by 745
Lysosomes as a therapeutic target
Bonam, S. R., Wang, F., & Muller, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0036-1 · Cited by 759
Sphingolipid metabolism diseases
Kolter, T., & Sandhoff, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.027 · Cited by 367
Synthesis and Conformational and Biological Aspects of Carbasugars
Arjona, O., Gómez, A. M., López, J. C., & Plumet, J. (2007) · Chemical Reviews · doi:10.1021/cr0203701 · Cited by 330
GM1 gangliosidosis: Review of clinical, molecular, and therapeutic aspects
Brunetti-Pierri, N., & Scaglia, F. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.04.012 · Cited by 302
Metadata
- Authors
- Matsuda, J., Suzuki, O., Oshima, A., Yamamoto, Y., Noguchi, A., Takimoto, K., Itoh, M., Matsuzaki, Y., Yasuda, Y., Ogawa, S., Sakata, Y., Nanba, E., Higaki, K., Ogawa, Y., Tominaga, L., Ohno, K., Iwasaki, H., Watanabe, H., Brady, R. O., & Suzuki, Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-12-15
- Volume
- 100
- Issue
- 26
- Pages
- 15912-15917
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2147001430
- Cited by
- 262
- References
- 23
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chemical chaperone therapy for brain pathology in G M1 -gangliosidosis. https://app.cochat.ai/papers/10.1073/pnas.2536657100
- The paper
- Matsuda, J., Suzuki, O., Oshima, A., Yamamoto, Y., Noguchi, A., Takimoto, K., Itoh, M., Matsuzaki, Y., Yasuda, Y., Ogawa, S., Sakata, Y., Nanba, E., Higaki, K., Ogawa, Y., Tominaga, L., Ohno, K., Iwasaki, H., Watanabe, H., Brady, R. O., & Suzuki, Y. (2003). Chemical chaperone therapy for brain pathology in G M1 -gangliosidosis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2536657100
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.